Hypervision Surgical develops AI-powered hyperspectral imaging technology that provides tissue analysis and visualization during surgery.
Hypervision Surgical has raised $23.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Hypervision Surgical's investors include IP Group, Heal Capital, redalpine, Life Extension Ventures, Angelini Ventures.
Hypervision Surgical is headquartered in London, United Kingdom.
Hypervision Surgical develops AI-powered hyperspectral imaging technology that provides tissue analysis and visualization during surgery.
Hypervision Surgical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hypervision Surgical — Funding & Investors." VCBacked, April 29, 2026, https://www.vcbacked.co/company/hypervision-surgical. Accessed September 7, 2026.
VCBacked. (2026). Hypervision Surgical — Funding & Investors. Retrieved September 7, 2026, from https://www.vcbacked.co/company/hypervision-surgical
{{cite web |title=Hypervision Surgical — Funding & Investors |url=https://www.vcbacked.co/company/hypervision-surgical |website=VCBacked |access-date=September 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated